NTRA · Natera Inc
United States · RS rating 92 · As of 2026-11-03
| Price | 388.63 USD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 38 / 94 / 93 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 58 / 77 / 38 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +21.7% |
| Sales growth Q/Q | +12.4% |
| Distance from 52-week high | +10.9% |
| Market cap (USD) | $28.5B |